Abstract:Objective: Cystic echinococcosis (CE), a zoonotic parasitic disease caused by Echinococcus granulosus, remains a public health and socioeconomic issue worldwide, making its prevention and treatment of vital importance. The aim of this study was to investigate changes in the intestinal microbiota of mice immunized with three peptide vaccines based on the recombinant antigen of E. granulosus, P29 (rEg.P29), with the hope of providing more valuable information for the development of vaccines against CE. Methods: Three peptide vaccines, rEg.P29T , rEg.P29B , and rEg.P29T + B , were prepared based on rEg.P29, and a subcutaneous immunization model was established. The intestinal floras of mice in the different immunization groups were analyzed by 16 S rRNA gene sequencing. Results: The intestinal microbiota analysis at both immunization time points revealed that Firmicutes, Bacteroidota, and Verrucomicrobiota were the predominant flora at the phylum level, while at the genus level, Akkermansia, unclassified_Muribaculaceae, Lachnospiraceae_NK4A136_group, and uncultured_rumen bacterium were the dominant genera. Some probiotics in the intestines of mice were significantly increased after immunization with the peptide vaccines, such as Lactobacillus_taiwanensis, Lactobacillus_reuteri, Lachnospiraceae_NK4A136_group, Bacteroides_acidifaciens, and so forth. Meanwhile, some harmful or conditionally pathogenic bacteria were decreased, such as Turicibacter sanguinis, Desulfovibrio_fairfieldensis, Clostridium_sp, and so forth, most of which are associated with inflammatory or infectious diseases. Kyoto Encyclopaedia of Genes and Genomes enrichment analysis revealed that the differential flora were enriched in multiple metabolic pathways, primarily biological systems, human diseases, metabolism, cellular processes, and environmental information processing. Conclusion: In this study, we comprehensively analyzed and compared changes in the intestinal microbiota of mice immunized with three peptide vaccines as well as their related metabolic pathways, providing a theoretical background for the development of novel vaccines against E. granulosus.

Identification of a dominant murine T-cell epitope in recombinant protein P29 from <italic>Echinococcus granulosus</italic>

Optimizing Sheep B-cell Epitopes in Echinococcus Granulosus Recombinant Antigen P29 for Vaccine Development

Cloning, Expression, and Protective Immunity in Mice of a Gene Encoding the Diagnostic Antigen P-29 of Echinococcus Granulosus.

Dynamic Monitor on Immunologic Protective Mechanism in Mice Inducedby Recombinant Echinococcus granulosus p-29 Protein (Reg.P-29)

Bioinformatic prediction and identification of immunogenic epitopes of the antigenic 14-3-3 protein of <i>Echinococcus multilocularis</i>

Immunoprotective Effect and Mechanism of Reg.p29 Against CD4+ T Cell-Deficient Mice with Echinococcus Multilocularis Infection

Identification of Combined T-cell and B-cell Reactive Echinococcus Granulosus 95 Antigens for the Potential Development of a Multi-Epitope Vaccine

Bioinformatics and Expression Analysis of Ubiquitin-conjugating Enzyme Gene Family of Echinococcus granulosus

Immunization of Mice with Egg1y162-1/2 Provides Protection Against Echinococcus Granulosus Infection in BALB/c Mice

Bioinformatic Features and Immunological Response of Recombinant Antigen CTLA4-IgV-EgG1Y162 Against Echinococcus Granulosus

Bioinformatics Analysis of EgA31 and EgG1Y162 Proteins for Designing a Multi-Epitope Vaccine Against Echinococcus Granulosus.

Changes in intestinal flora of mice induced by rEg.P29 epitope peptide vaccines

Preparetion and analysis on the immunogenicity of Echinococcus granulosus-specific diagnostic antigen Eg-07279

Identification of Epitopes in Echinococcosis Multilocularis 14-3-3 Antigen: A Bioinformatics Approach

The Prediction of T- and B-combined Epitope and Tertiary Structure of the Eg95 Antigen of Echinococcus Granulosus.

Prokaryotic Expression and Immunologic Identification of P-29 Gene from Echinococcus Granulosus Hydatid Cyst

Immunogenicity Study of E. G EF - 1 Recombinant Antigen of Echinococcusis Granulosus

Design of a Novel Multi-Epitope Vaccine Against Echinococcus granulosus in Immunoinformatics

Design and functional preliminary investigation of recombinant antigen EgG1Y162-EgG1Y162 against Echinococcus granulosus .

Prokaryotic Expression and Identification of B- and T-cell Combined Epitopes of Em95 Antigen of Echinococcus Multilocularis.

Prediction and Identification of Epitopes in the Echinococcus Multilocularis Thrombospondin 3 Antigen

Identification of a dominant murine T-cell epitope in recombinant protein P29 from &lt;italic&gt;Echinococcus granulosus&lt;/italic&gt;